Improving clinical outcomes of Barrett’s esophagus with high dose proton pump inhibitors and cryoablation

INTRODUCTION: Esophageal adenocarcinoma incidence has increased significantly despite surveillance endoscopy for Barrett’s esophagus (BE) and gastric acid supression medications. This prospective, cohort study’s aims were to determine the long-term efficacy of proton-pump inhibitors twice daily (PPI...

Descripción completa

Detalles Bibliográficos
Autor principal: Snady, Harry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Gastroenterology & Hepatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10228298/
https://www.ncbi.nlm.nih.gov/pubmed/37232568
http://dx.doi.org/10.1080/07853890.2023.2191002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10228298/
https://www.ncbi.nlm.nih.gov/pubmed/37232568
http://dx.doi.org/10.1080/07853890.2023.2191002

Ejemplares similares